Effect of ticagrelor combined with nicorandil on endothelial function and coronary blood flow after PCI treatment in STEMI patients

被引:0
|
作者
Li, Guiru [1 ]
Yue, Dongmei [1 ]
机构
[1] Shanghai Univ Med & Hlth Sci, Affiliated Chongming Hosp, Dept Cardiol, Shanghai 202150, Peoples R China
关键词
STEMI; PCI; Ticagrelor; Nicorandil;
D O I
10.22514/sv.2024.147
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This study investigated the effect of ticagrelor combined with nicorandil on endothelial function and coronary blood flow after percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). We retrospectively analyzed 300 STEMI patients who underwent emergency PCI, 150 in the observation group and 150 in the control group. The control group was given oral ticagrelor. The observation group received oral nicorandil along with the control group. A significant improvement in peak ejection rate (PER) and left ventricular (LV) ejection fraction (EF) occurred after the operation, while LV end-diastolic volume index (LVESVI), LV end-diastolic internal diameter (LVEDD), cardiac troponin I (cTnI), and creatine kinase myoglobin (CK-MB) were significantly reduced compared to the preoperative period. Improvements in cardiac function were significantly greater in the observation group than in the control group (p < 0.05). After the operation, both groups' serum nitric oxide (NO) and endothelin-1 (ET-1) levels were greatly higher and lower, respectively, during the preoperative period (p <0.05). The observation group's serum NO level was significantly higher than the control group's, and its ET-1 level was substantially lower than the control group's (p < 0.05). There was a significant increase in thrombolysis in myocardial infarction (TIMI) flow grade 3 percentage and TIMI myocardial perfusion grade (TMPG) grade 3 percentage in the observation group in the immediate postoperative period compared to the control group, despite a significantly lower corrected TIMI Frame count (CTFC) (p < 0.05). 1 month postoperatively, major adverse cardiovascular events (MACE) incidence was significantly lower in the observation group than in the control group (chi(2) = 3.914, p = 0.048). The preoperative combination of ticagrelor and nicorandil in STEMI patients undergoing PCI helped attenuate vascular endothelial function impairment, improved coronary blood flow, and promoted postoperative cardiac function recovery.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 50 条
  • [21] CoO Nanoparticles Combined with MRI: Analysis of No-Reflow in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCI and the Effect of Coronary Nicorandil
    Liang, Xiangwen
    Li, Ping
    Xie, Wenchao
    Lin, Zhihai
    Li, Yiyi
    Liao, Wang
    Liu, Ming
    CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (03) : 390 - 401
  • [22] EFFECT OF TICAGRELOR AND CLOPIDOGREL ON PLATELET AGGREGATION FUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Sui, Z.
    Qu, P.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (02): : 439 - 445
  • [23] Myocardial blood flow and coronary endothelial function early after heart transplantation.
    Preumont, N
    Lenaers, A
    Vachiery, JL
    Wikler, D
    Damhaut, P
    Degre, S
    Berkenboom, G
    Goldman, S
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 321 - 321
  • [24] Clinical Therapeutic Effect of Ticagrelor for Complicated Coronary Artery Disease Patients Undergoing PCI
    Zeng, D. L.
    Duan, X. Y.
    Fan, W. W.
    Chen, H.
    Li, J. H.
    Wu, K.
    Ruan, F. H.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S474 - S474
  • [25] The Effect of Atorvastatin on Inflammatory Markers and Endothelial Function in Patients with ACS Before and After PCI
    Zhang Xiaojuan
    CIRCULATION, 2010, 122 (02) : E221 - E221
  • [26] Prognostic Value of Coronary No-reflow Phenomenon After Primary PCI in Patients with STEMI
    Khuyag, Batmyagmar
    Chimed, Surenjav
    Baldandorj, Amarjargal
    Zundui, Lkhagvasuren
    Davaakhuu, Narantuya
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (16) : S11 - S11
  • [27] The effect of PCI and post procedural TIMI flow on patients with late arrival STEMI
    Tarabih, M.
    Ovdat, T.
    Karkabi, B.
    Eitan, A.
    Maguli, B.
    Mahamid, M.
    Shiran, A.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [28] The impact of the emergency treatment and primary PCI in coping with a coronary heart disease one year after STEMI - The patients' perspective
    Mentrup, S.
    Schnepp, W.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2014, 13 : S7 - S8
  • [29] Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow
    Niu, Hongmei
    Wei, Zhenzhen
    Zhang, Yanling
    He, Jian
    Jia, Danyan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (01) : 904 - 908
  • [30] Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
    Wang, Zhe
    Zhou, Da-Yan
    Su, Yong
    Si, Liang-Yi
    Xu, Qiang
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)